Business Description
Orient Pharma Co Ltd
SIC : 111
ISIN : TW0004166004
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.43 | |||||
Debt-to-EBITDA | 4.16 | |||||
Interest Coverage | 2 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.43 | |||||
Beneish M-Score | -1.65 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.9 | |||||
3-Year FCF Growth Rate | 15.5 | |||||
3-Year Book Growth Rate | 4.8 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.56 | |||||
9-Day RSI | 70.28 | |||||
14-Day RSI | 71.23 | |||||
6-1 Month Momentum % | 3.54 | |||||
12-1 Month Momentum % | 4.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.1 | |||||
Quick Ratio | 0.69 | |||||
Cash Ratio | 0.2 | |||||
Days Inventory | 181.83 | |||||
Days Sales Outstanding | 54.93 | |||||
Days Payable | 44.23 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6 | |||||
Shareholder Yield % | -4.69 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 52.66 | |||||
Operating Margin % | 3.12 | |||||
Net Margin % | 2.51 | |||||
FCF Margin % | -19.83 | |||||
ROE % | 1.52 | |||||
ROA % | 0.96 | |||||
ROIC % | 1.28 | |||||
ROC (Joel Greenblatt) % | 3.15 | |||||
ROCE % | 2 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 270.5 | |||||
PE Ratio without NRI | 241.52 | |||||
PS Ratio | 6.79 | |||||
PB Ratio | 3.61 | |||||
Price-to-Tangible-Book | 5.3 | |||||
EV-to-EBIT | 180.23 | |||||
EV-to-EBITDA | 38.51 | |||||
EV-to-Revenue | 7.46 | |||||
EV-to-FCF | -36.53 | |||||
Price-to-Median-PS-Value | 0.7 | |||||
Price-to-Graham-Number | 7.53 | |||||
Earnings Yield (Greenblatt) % | 0.55 | |||||
FCF Yield % | -2.94 |